Skip to main content
OpenTrials

Clinical trial condition

Gastric Cancer

Explore clinical trials studying Gastric Cancer. Study availability and eligibility vary by location and protocol.

1,117 public trials 273 recruiting studies
Refine in advanced search Browse all conditions

Gastric Cancer trial results

Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

NCT04868877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
Locations
  • University of California, Irvine Orange, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
  • Next Oncology Virginia Fairfax, Virginia, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

NCT03399110

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jiangsu Cancer Hospital Nanjing, China
View Trial Details
Active, Not Recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details

Related conditions